01664nam 2200397Ia 450 991069571300332120070427115844.0(CKB)5470000002372655(OCoLC)123760638(EXLCZ)99547000000237265520070427d2007 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierDrug safety[electronic resource] FDA needs to further address shortcomings in its postmarket decision-making process : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /statement of Marcia Crosse[Washington, D.C.] :U.S. Govt. Accountability Office,[2007]13 pages digital, PDF fileTestimony ;GAO-07-599 TTitle from title screen (viewed on Apr. 26, 2007)."For release ... March 22, 2007."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Drug safety DrugsUnited StatesSafety measuresDrugsSafety measures.Crosse Marcia1380679United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Oversight and Investigations.United States.Government Accountability Office.GPOGPOBOOK9910695713003321Drug safety3449630UNINA